LEADER 02986nam 2200589Ia 450 001 9910438001303321 005 20200520144314.0 010 $a1-4419-0787-4 024 7 $a10.1007/978-1-4419-0787-5 035 $a(CKB)2670000000279068 035 $a(EBL)1156108 035 $a(OCoLC)831115632 035 $a(SSID)ssj0000798538 035 $a(PQKBManifestationID)11425163 035 $a(PQKBTitleCode)TC0000798538 035 $a(PQKBWorkID)10742739 035 $a(PQKB)10096310 035 $a(DE-He213)978-1-4419-0787-5 035 $a(MiAaPQ)EBC1156108 035 $a(PPN)168290898 035 $a(EXLCZ)992670000000279068 100 $a20121116d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDiagnostic pathology of pleuropulmonary neoplasia /$fAnnikka Weissferdt, Cesar A. Moran 205 $a1st ed. 2013. 210 $aNew York $cSpringer$d2013 215 $a1 online resource (474 p.) 300 $aDescription based upon print version of record. 311 $a1-4419-0786-6 320 $aIncludes bibliographical references and index. 327 $a1. Diagnostic Imaging of Lung and Pleural Tumors -- 2. The Staging of Lung Cancer -- 3. Non-Small Cell Carcinomas -- 4. Neuroendocrine Carcinomas -- 5. Biphasic Tumors of the Lungs -- 6. Salivary Gland and Adnexal Type Tumors of the Lungs -- 7. Tumors Derived from Presumed Ectopic Tissues -- 8. Vascular Tumors of the Lungs -- 9. Mesenchymal Tumors of the Lungs -- 10. Lung Tumors of Uncertain Histogenesis -- 11. Malignant Lymphomas Involving Lung and Pleura -- 12. Tumors of the Pleura -- 13. Tumor-Like and Benign Tumors of the Lung -- 14. Molecular Pathology of Lung Cancer. 330 $aDiagnostic Pathology of Pleuropulmonary Neoplasia highlights the morphologic basis, immunohistochemistry, electron microscopy, and molecular biology of tumoral and pseudotumoral conditions of the lung and pleura. The volume also highlights the nuances in the diagnosis of lung and pleural conditions and the applications of today?s most recent studies in molecular biology, and the way it is applied to diagnosis and treatment. In providing an expert guide for the histopathologic diagnosis of lung and pleural tumors, this volume be of great interest to general surgical pathologists, surgeons, oncologists, and those involved in the management of patients with lung tumors. 606 $aTumors$xPathophysiology 606 $aLungs$xCancer$xPathophysiology 615 0$aTumors$xPathophysiology. 615 0$aLungs$xCancer$xPathophysiology. 676 $a616.99/424 676 $a616.99424 676 $a616.99424075 700 $aWeissferdt$b Annikka$0891351 701 $aMoran$b Cesar$0782608 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910438001303321 996 $aDiagnostic pathology of pleuropulmonary neoplasia$94187511 997 $aUNINA LEADER 04454nam 2201345z- 450 001 9910557678203321 005 20220111 035 $a(CKB)5400000000044751 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76605 035 $a(oapen)doab76605 035 $a(EXLCZ)995400000000044751 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCatalytic Transformation of Renewables (Olefin, Bio-sourced, et. al) 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (248 p.) 311 08$a3-0365-1068-0 311 08$a3-0365-1069-9 330 $aThe objective of this Special Issue is to provide new contributions in the area of biomass valorization using heterogeneous catalysts and focusing specifically on the structure/activity relationships of specific and important oxidation, hydrogenation, hydrodeoxygenation and biocatalytic processes. The issue emphasizes the influence of the design and morphology of the catalyst, in terms of particle size, redox and acid-base properties and catalyst stability. Finally, mechanistic studies and examples of design and optimization of industrial processes are presented. 517 $aCatalytic Transformation of Renewables 606 $aResearch & information: general$2bicssc 606 $aTechnology: general issues$2bicssc 610 $a2 methyl-furan 610 $a2,5-furandicarboxylic acid 610 $a5-(hydroxymethyl)furfural 610 $aab initio 610 $aacid-base characterization 610 $aadiabatic reactor 610 $aalkylation 610 $abase-free 610 $abimetallic nanoparticles 610 $abio-based platform chemicals 610 $abiocatalysis 610 $abiomass 610 $abiomass conversion 610 $acapping agent 610 $acatalysis 610 $acatalyst design 610 $acatalytic hydrogen transfer reduction 610 $acellobiose 610 $achemical modification 610 $aCo/SBA-15 610 $acolloidal synthesis 610 $across-flow autohydrolysis 610 $adiffusion 610 $adry gel conversion 610 $aembedded catalysts 610 $aEucalyptus globulus wood 610 $aFischer-Tropsch synthesis 610 $afuran-2-acrolein 610 $afurans 610 $afurfural 610 $afuroic acid 610 $aglucose 610 $aglycosidation 610 $agold 610 $agold catalysis 610 $agreen oxidation 610 $aH-ZSM-5 610 $ahemicellulose-derived products 610 $aHMF 610 $ahydrodeoxygenation 610 $ahydrogenation 610 $ahydrolytic hydrogenation 610 $ahydrotalcite 610 $ain-situ synthesis 610 $aindustrial design 610 $airon 610 $aisomorphous substitution 610 $akinetic modeling 610 $amagnesium oxide 610 $aMCM-41 610 $amethanol 610 $amethylbutynol test reaction 610 $aMFI zeolite 610 $aMPV reaction 610 $amultiscale modeling 610 $an/a 610 $ananoparticles 610 $anickel phosphide 610 $aoxidation 610 $aoxidative condensation 610 $apalladium 610 $aparticle size 610 $aparticle sizes 610 $aPd-based catalysts 610 $apore length 610 $apore size 610 $areduction 610 $aselective oxidation 610 $asilica sources 610 $aSn-Beta zeolite 610 $asol-immobilization 610 $asolid acid 610 $asolid base 610 $asorbitol 610 $awhole cells 610 $azeolite catalysis 610 $azeolites 615 7$aResearch & information: general 615 7$aTechnology: general issues 700 $aDimitratos$b Nikolaos$4edt$01322383 702 $aAlbonetti$b Stefania$4edt 702 $aTabanelli$b Tommaso$4edt 702 $aDimitratos$b Nikolaos$4oth 702 $aAlbonetti$b Stefania$4oth 702 $aTabanelli$b Tommaso$4oth 906 $aBOOK 912 $a9910557678203321 996 $aCatalytic Transformation of Renewables (Olefin, Bio-sourced, et. al)$93034938 997 $aUNINA